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Background: The Dutch National Immunisation Programme includes six tetanus toxoid (TT) vaccinations and
reaches a high rate of vaccination coverage. In the Netherlands, several guidelines related to tetanus post-exposure
prophylaxis (T-PEP) are in place. In 2003, the Dutch Health Council (HC) reviewed the use of T-PEP. The aim of this
study is to evaluate whether the HC recommendations have been implemented.
Methods: We asked 178 Dutch General Practitioner (GP) offices and 60 Emergency Departments (EDs) to participate in
a cross-sectional questionnaire study and requested that participating facilities send in the T-PEP guidelines adopted by
their practice. The differences, based on categories mentioned in the HC recommendations, between GPs and EDs and
the type of T-PEP guidelines adopted were assessed.
Results: The response rates for the GPs and EDs were 38% (n = 67) and 70% (n = 42), respectively. 98% percent
(n = 107) of the participants reported having T-PEP guidelines. Of the guidelines described in the survey responses, 28%
(n = 23; EDs 41%, GPs 21%) were consistent with the HC-recommendations, 36% (n = 29; EDs 7%, GPs 52%) adhered to
the guidelines of the College of GPs (CGP), which restricts the use of T-PEP to tetanus prone wounds but for these
wounds is in line with the recommendations of the HC. The remaining 36% had adopted other guidelines, most of
which can lead to over-prescription of T-PEP. Information on T-PEP was lacking in patients with higher risk vaccination
histories.
Conclusion: Almost all participants have adopted T-PEP guidelines. Strict adherence to the HC recommendations is
low. More than half of GPs have adopted the more restrictive CGP-guideline, which limits T-PEP to tetanus prone
wounds.
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Tetanus is a serious infectious disease that can be lethal
when left untreated. Even treated, the disease’s mortal-
ity rate is between 10-40% [1]. Tetanus is caused by
Clostridium tetani and is not contagious. Spores of the
tetanus bacillus, which are present in the soil and in
the faeces of domestic animals, can enter the body
through a wound. Anaerobic conditions can then lead
to production of the neurotoxin tetanospasmin, which
causes muscle contractions and spasms [2,3].
Tetanus infection occurs worldwide, though there are
only few cases each year in developed countries (includ-
ing the Netherlands) due to large scale immunisation
programmes [4,5]. The Netherlands started its National
Immunisation Programme (NIP) in 1957. Currently,
tetanus vaccinations are given at two, three, four and
11 months and at four and nine years of age [6]. Fur-
thermore, in 2002, the NIP began administering Menin-
gococcus serogroup C vaccines conjugated to tetanus
toxoid (TT) to 14-month-old children and implemented a
catch up campaign for those up to 19 years of age. This
vaccination also boosts the immune response against tet-
anus [6,7]. In contrast to other countries, the Netherlands
does not supply a regular booster for adults. As a result of
continuously high NIP coverage, the seroprevalence of
tetanus antibodies in the Netherlands is 94% [6].
High vaccination coverage is important because vac-
cination with TT is the only way to immunise against
tetanus [7]. A full course of TT for never vaccinated
wounded patients involves three vaccinations at months
zero, one and seven. TT does not induce immunity imme-
diately; after the second dose, it takes approximately
two to four weeks to exceed the minimum level re-
quired for short-term protection (0.01 IU/ml). There-
fore, human anti-tetanus immunoglobulin (TIG) is
indicated for all persons at risk of contracting tetanus
after being wounded if they are not (fully) vaccinated
or are immuno-compromised [4].
The use of different protocols and the presumption
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Fully vaccinated patients completed the primary series of vaccinations (e.g., vaccinaa 2003 review of the tetanus post-exposure prophylaxis
(T-PEP) use by the Dutch Health Council (HC). The HC
is an independent scientific advisory board, which advises
the government. A multidisciplinary team of experts
writes guidelines and advices based on latest evidence
[8]. Therefore, the authors considered the HC recom-
mendations as the reference standard. The only factors
in determining whether to administer T-PEP, according
to the HC guidelines, are a patient’s vaccination history
and eligibility for the NIP, based on the year of birth
(Table 1) [9]. The Dutch College of General Practi-
tioners (CGP) states to use T-PEP only in tetanus prone
wounds. For these wounds the CGP guideline is in line
with the HC recommendations. The CGP guideline
does not prescribe T-PEP in case of a non-tetanus prone
wound. Differentiation between prone and non-prone
wound types is determined by the likelihood that a
wound is contaminated with C. tetani spores [10]. GPs
differentiate the wound before consulting the patient’s
vaccination history.
In 2011, five cases of tetanus were reported in the
Netherlands. In three of those cases, patients contacted
physicians for wound care, two directly after being
injured and the other after two days because of an infec-
tion. In all three cases, T-PEP was not sufficient. It is
therefore useful to evaluate whether the current recom-
mendations related to T-PEP are properly implemented
in clinical care [5]. The objective of this study is to
assess whether the HC recommendations regarding T-PEP
are in place and to evaluate the adoption of T-PEP guide-
lines that do not conform to the HC recommendations.
Methods
Participants
General practitioner (GP) offices and emergency depart-
ments (EDs) in the Netherlands were asked to participate
in this cross-sectional study. At least five GPs were se-
lected from each of the 12 provinces of the Netherlands.
EDs were also chosen based on their distribution across
the country. Potential participants were contacted byphylaxis after injury published by the Dutch Health
Administration of TIG Vaccination with TT
Yes Three times
Yes Three times
Yes Complete to three times
born before 1950) Yes One time




ted with TT three times).
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sionals who were willing to participate. A sample size
calculation suggested that to estimate 20% (±10%) non-
adherence (defined as aberrant for at least one aspect of
the HC recommendations), with α = 0.05, at least 62
GPs and 40 EDs should be included in the study.
The study comprised on a short questionnaire resulting
in a very limited burden to participants (i.e. professionals).
For this reason no ethical approval was requested
according to the Dutch Medical Research Involving
Human Subjects Act (WMO) [11].
Questionnaire
The questionnaire was sent either by post or by an email
invitation to fill out an online questionnaire. Only one
person per practice or department needed to fill out the
questionnaire. The questions concerned the size of the
practice, number of wounds observed and T-PEP treat-
ments given, knowledge regarding the annual number of
tetanus cases in the Netherlands, guidelines adopted at
the responding facility and reasons for choosing those
guidelines. Participants were asked to indicate whether
they used no guidelines at all, the guidelines from the
World Health Organization (WHO), the guidelines from
the CGP, the guidelines from the LCI (based on the HC
recommendations) or other guidelines. Additionally, the
participants were asked to provide a copy of their guide-
lines or protocol related to T-PEP. The provided guide-
lines were scored according to their conformity with the
HC recommendations, which were considered as the
reference standard in this study.
Analysis
Along with descriptive statistics, the T-PEP type was
categorised based on the HC recommendations, and
differences between the guidelines adopted by GPs and
EDs were assessed. Finally, we determined the overall
percentage of guidelines that conformed to the HC
recommendations.
Statistical analyses were performed using SAS 9.3 for
Windows (SAS Institute Inc., Cary, NC, USA).
Results
In total, 178 GP offices and 60 EDs were contacted.
Fifty-one GPs directly declined to participate in the
study, whereas none of the approached EDs initially
declined to participate. The reasons for non-participation
varied, with GPs indicating that they were already too busy
(45%, n = 23), not interested (26%, n = 13) or never partici-
pated in any research (16%, n = 8); seven GPs declined
without providing a reason. Sixty GPs and 18 EDs did not
return the questionnaire after initially agreeing to parti-
cipate. In total, 67 GP offices and 42 EDs returned thequestionnaire and participated in this study, resulting in
response rates of 38% and 70%, respectively.
General information on practices and tetanus (post-exposure
prophylaxis)
General practitioners
The median number of GPs per practice was three
(range 1–8), and the median number of patients per
office was 3600 (range 1200–14700). All GPs stated that
they occasionally prescribed and administered T-PEP in
their offices (range <1 – 20 per month). Ninety-nine per-
cent of the participating offices (n = 66) reported that
T-PEP guidelines had been adopted. Only one of the
GPs responded that no guidelines were in use, reporting
that the guidelines for T-PEP were too complicated.
Emergency departments
The median number of patients visiting the responding
EDs in 2011 was 22344 (range 1500–46000). The fre-
quency of T-PEP administration at those EDs ranged
from never to hundreds per week. 98% of the participat-
ing EDs (n = 41) reported that they had adopted T-PEP
guidelines. Only one ED responded that no guidelines
had been adopted because of limited access to the
guidelines.
Knowledge regarding the number of tetanus cases
The range of answers to the question of how many
tetanus cases occurred annually in the Netherlands was
quite large (between zero and more than one hundred).
Sixteen participants stated that they had no idea of the
number of cases. Eighty-five percent (n = 79) of the
answers were between one and ten (Figure 1).
Guidelines
In total, 98% (n = 107; 66 GPs and 41 EDs) of the partici-
pating facilities had adopted T-PEP guidelines (Figure 2).
Of the GP offices, 52 (78%) sent a copy of their guide-
lines. The guidelines provided conformed to HC recom-
mendations and CGP guidelines (i.e., according to HC
recommendations in Table 1 but only in the tetanus
prone cases) in 11 (21%) and 27 (52%) cases, respect-
ively. The remaining GPs (n = 14, 27%) used their own
or other T-PEP guidelines; five of those GPs did not con-
sider the wound type as a criterion in their guidelines,
whereas nine did.
Of the EDs that had adopted T-PEP guidelines, 71%
(n = 29) provided copies. Twelve EDs (41%) fully adhered
to the HC recommendations. Two others (7%) conformed
to the CGP guidelines (HC recommendations for tetanus
prone wounds only). Two departments (7%) reported
that they were not aware of the HC recommendations,
although they used guidelines that were based partly on






































Figure 1 Participant estimations (by percentage) of the number of annual tetanus cases in the Netherlands.
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remaining EDs (n = 15, 52%) had adopted their own
T-PEP guidelines or other alternate guidelines; seven of
those did not consider the wound type as a criterion,
whereas eight did.
In facilities that used guidelines other than those based
on the HC recommendations or the CGP guidelines (14
GPs and 15 EDs), non-adherence largely resulted in over-
immunisation or missing information in certain categories
of the vaccination history (Table 2).
Discussion
Our survey studying the adherence to T-PEP guidelines
showed that almost all participating GPs and EDs had
adopted T-PEP guidelines. Less than one-third of the
guidelines were fully consistent with the published HC
recommendations, which are considered the reference
standard (provided by a consensus of experts) [9]. Another
36% of the guidelines included the CGP suggestion to re-
strict the T-PEP use to tetanus prone wounds only, whichFigure 2 Adoption of guidelines for tetanus post-exposure prophylax
departments (EDs) in the Netherlands in 2012. The guidelines of the CG
wound’ as a criterion for determining whether T-PEP is appropriate. On allmight lead to under immunisation. The remainder of
the adopted guidelines mainly resulted in over-immunisation
when compared with the HC recommendations or provided
inadequate information for specific categories of the
vaccination history.
The percentage of Dutch GPs and EDs that had
adopted T-PEP guidelines (98%) is somewhat higher
than the 92% reported by Slottje et al. in 2001; that
study took place before the HC review in 2003 and only
included EDs [12].
The HC recommendations regarding T-PEP are based
entirely on the patient’s vaccination history. TT and TIG
are both recommended irrespective of the nature and
origin of the wound [9]. By contrast, the CGP guidelines
restrict the use of both TT and TIG to tetanus-prone
wounds, such as those in contact with faeces, soil and
dirt. The CGP notes that it is infeasible to obtain a pa-
tient’s vaccination status on every wound consultation
due to high numbers of contacts [10]. In our study, 28%
and 36% of responding Dutch health care facilities hadis as reported by general practitioners (GPs) and emergency
P differs from the HC recommendations only in that it uses ‘type of
other criteria, the two guidelines are identical.
Table 2 Absolute numbers (row percentages) of prescribed T-PEP in guidelines (n = 29) that were not based on the HC
recommendations or CGP guidelines in 2012
Vaccination history N (%) No prophy-laxis 1x TT 1x TT + TIG Complete TT
till 3 + TIG
3x TT + TIG No
informa-tion
General practioners (n=14)
Immuno-compromised * 10 (71) 4 (29)
Never vaccinated 1 (7) * 12 (86) 1 (7)
Incompletely vaccinated * 4 (29) 6 (42) 4 (29)
Fully vaccinated without documentation
(men born before 1936 and women before 1950)
* 10 (71) 4 (29)
Fully vaccinated without documentation
(men born in/after 1936 and women in/after 1950)
* 8 (57) 2 (14) 4 (29)
Fully vaccinated with booster ≥10 yrs ago. * 12 (86) 1 (7) 1 (7)
Fully vaccinated with booster <10 yrs ago. * 12 (86) 2 (14)1
Emergency departments (n = 15)
Immuno-compromised * 10 (67) 5(33)
Never vaccinated * 15 (100)
Incompletely vaccinated 2 (13) * 1 (7) 7 (47) 5 (33)
Fully vaccinated without documentation
(men born before 1936 and women before 1950)
* 10 (67) 2 (13) 3 (20)
Fully vaccinated without documentation
(men born in/after 1936 and women in/after 1950)
* 9 (60) 3 (20) 3 (20)
Fully vaccinated with booster ≥10 yrs ago. * 14 (93) 1 (7)2
Fully vaccinated with booster <10 yrs ago. * 14 (93) 1 (7)1
When the guideline contained no information on T-PEP for a specific group, the guideline was scored as no information.
*Recommendations of the HC.
1When vaccinated longer than five years ago, a dose of TT is administered.
2When vaccinated longer than 15 years ago, both TT and TIG are administered.
Donken et al. BMC Family Practice 2014, 15:112 Page 5 of 7
http://www.biomedcentral.com/1471-2296/15/112adopted guidelines consistent with the HC recommen-
dations and CGP guidelines, respectively. Since one
might expect higher response of “best” performing (or
highly interested practices) could lead to selection bias
due to non-participation, these estimates might be an
overestimation of the health care facilities which use a
guideline for T-PEP in general and for the HC recom-
mendation and CGP guidelines in specific.
Our study suggests that participating facilities that do not
adhere to the HC recommendations or the CGP guidelines
probably over-immunised (in)completely vaccinated pa-
tients, unnecessarily increasing the risk of side effects and
costs [2,13]. However, in the categories for unvaccinated,
probably vaccinated and immuno-compromised patients, a
high percentage (20% to 33%) of guidelines not conforming
to the HC recommendations contained no information on
T-PEP prescriptions. Previous research on T-PEP among
these specific groups has shown that increased tetanus risk
coincided with an increased risk of under-prescription of
T-PEP [13-15]. Under prescription might lead to a higher
risk of developing tetanus. The consequences of a tetanus
infection are still enormous. Even in developed countries,
mortality is high and patients are often hospitalized for a
long time.The use of guidelines conforming to the CGP recom-
mendations theoretically might result in a slightly higher
risk of tetanus. However, the risk of tetanus contamin-
ation in a clean wound is very low, and the anaerobic
conditions that are needed for spore germination are less
likely to occur in superficial wounds [4,16-18]. On an
individual basis, the risk of a patient visiting a facility
using the CGP guideline to contract tetanus due to in-
sufficient T-PEP is small.
However, vaccinating every wounded patient regard-
less of wound type also provides future protection from
tetanus. This is consistent with the current British and
American guidelines, which suggest evaluating the wound
type and vaccination history simultaneously; anyone with
incomplete, unknown or uncertain vaccination status and
clean wounds is eligible for vaccination with TT to ensure
future protection, as prophylaxis by TT takes time before
boosting immunity [4,16,19]. For wounds that are consid-
ered tetanus prone, TIG is also administered [3,4].
The five Dutch tetanus case reports indicate that
T-PEP was not adequately administered to elderly pa-
tients born before the NIP was introduced; three of
these patients contacted physicians about wounds after
falling on the street or stepping on a rusty nail, two did
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tetanus for individuals born before the NIP was intro-
duced, a catch-up campaign for the elderly could be
considered. A quick calculation using Dutch data sug-
gests that vaccinating every ten years all of the elderly
born before 1951 (instead of maintaining the current
strategy) would cost over five million euro per add-
itional avoided tetanus case in the first ten years. In
2013, there were 3.454.500 people in the Netherlands
born before 1951 [20]. If all receive a three dose series
of TT (€5.43 per dose) administered at the GP (€4.34 per
vaccination) the total campaign would cost €101.251.395,-
[21,22]. The last years showed in this age group mean
number of tetanus cases of two per year. Assuming an ef-
fectiveness of ten years this would prevent twenty cases.
Therefore, a decennial tetanus booster for Dutch elderly is
not likely to be cost-effective.
In this study, only presence of T-PEP guidelines was
examined. Individual adherence of these guidelines was
not examined. Previous research in other countries showed
that compliance to T-PEP guidelines was poor [15,23,24].
One difficulty of adhering to the T-PEP guidelines is
obtaining a patient’s appropriate vaccination history [13].
The patient reported history seems to be an unreliable
method for acquiring a patient’s immune status [25-28].
The use of a Tetanus Quick Stick, a bedside test that de-
termines a patient’s immune status in 10 minutes, seems
to be a good alternative [15,26-33]. The price of such
bedside test is €5.70 per test [33]. Further research
investigating the applicability of this test in the
Netherlands is currently underway; the study will also
generate more insight regarding individual adherence to
T-PEP guidelines in the Netherlands. [ NCT3530, Dutch
Trial Registry, http://www.trialregister.nl/trialreg/admin/
rctview.asp?TC=3530].
There are some limitations to this study. Facilities
without T-PEP guidelines might have declined to par-
ticipate, resulting in selection bias. Additionally, this
study covers only a small sample of all facilities
involved in emergency care in the Netherlands; the
sampling procedures were not completely random.
Therefore, we cannot be certain that the facilities
included in the study were a representative sample.
Finally, this study only examined whether health care
facilities had adopted guidelines as well as which
guidelines had been adopted. Compliance with the
guidelines at these facilities was not studied; research
in other countries suggests that actual adherence to T-
PEP guidelines is poor [15,23,24].
Conclusions
Almost all participating GPs and EDs had adopted
guidelines for T-PEP. Forty-one percent of EDs and 28%
of GP offices adopted guidelines fully consistent with theHC recommendations. Tetanus awareness is important
for GPs and EDs, especially those treating incompletely
vaccinated or unvaccinated patients.
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